Burning Rock Biotech
BNR
18 hedge funds and large institutions have $13.2M invested in Burning Rock Biotech in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 2.51% → 2.5% (-0.01%)
10% less funds holding
Funds holding: 20 → 18 (-2)
13% less capital invested
Capital invested by funds: $15.1M → $13.2M (-$1.89M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RWMG
Redwood Wealth Management Group
Medford,
New Jersey
|
+$81.8K |
| 2 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$80.5K |
| 3 |
SIA
SkyView Investment Advisors
Shrewsbury,
New Jersey
|
+$76.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$19.6K |
| 5 |
SNN
Shen Neil Nanpeng
|
+$6.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$87.5K |
| 2 |
State Street
Boston,
Massachusetts
|
-$48.8K |
| 3 |
Morgan Stanley
New York
|
-$48.8K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$35.7K |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
-$22.1K |
BNR Hedge Fund Activity: Q2 2024 in Review
18 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q2 2024, worth a combined $13.2M — down 13% from $15.1M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BNR and 3 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 4 added.
The largest buyer was Redwood Wealth Management Group, opening a new position worth an estimated $81.8K. The largest seller was Massachusetts Financial Services, cutting an estimated $87.5K.
- 18 institutional investors held Burning Rock Biotech (BNR) as of Q2 2024, down from 20 in Q1 2024.
- Funds reported $13.2M of Burning Rock Biotech stock for Q2 2024, down 13% quarter-over-quarter.
- 3 funds opened new Burning Rock Biotech positions in Q2 2024 and 5 closed out, a net change of -2 holders.
- The largest Burning Rock Biotech buyer in Q2 2024 was Redwood Wealth Management Group, an estimated $81.8K added.
- The largest Burning Rock Biotech seller in Q2 2024 was Massachusetts Financial Services, an estimated $87.5K sold.
Based on aggregated 13F filings for Q2 2024.